Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell

Molecular Biology of the Cell

Volumn 14, Issue 1, 2003, Pages 78-92

  Temme, Achim ^a,b   Rieger, Michael ^a   Reber, Friedemann ^a   Lindemann, Dirk ^c   Weigle, Bernd ^a   Diestelkoetter Bachert, Petra ^a   Ehninger, Gerhard ^b   Tatsuka, Masaaki ^d   Terada, Yasuhiko ^d   Peter Rieber, Ernst ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELL PROTEIN; CHROMOSOME PROTEIN; HYBRID PROTEIN; SURVIVIN;

ANAPHASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL FUNCTION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CENTROMERE; CENTROSOME; CHROMOSOME; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINESIS; DYNAMICS; ENZYME BINDING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTERPHASE; MICROTUBULE; MITOSIS; MITOSIS SPINDLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TELOPHASE;

APOPTOSIS; CELL DIVISION; HELA CELLS; HUMANS; KINETOCHORES; LUMINESCENT PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MUTATION; NEOPLASM PROTEINS; RECOMBINANT FUSION PROTEINS;

ANIMALIA; VERTEBRATA;

EID: 12244293398     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E02-04-0182     Document Type: Article

References (46)

1. Adams, R.R., Wheatley, S.P., Gouldsworthy, A.M., Kandels-Lewis, S.E., Carmena, M., Smythe, C., Gerloff, D.L., and Earnshaw, W.C. (2000). INCENP binds the Aurora-related kinase AIRK2, and is required to target it to chromosomes, the central spindle, and cleavage furrow. Curr. Biol. 10, 1075-1078.
2. Ainsztein, A.M., Kandel-Lewis, S.E., Mackay, A.M., and Earnshaw, W.C. (1998). INCENP centromere and spindle targeting: identification of essential conserved motifs and involvement of heterochromatin protein HP1. J. Cell Biol. 7, 1763-1774.
3. Ambrosini, G., Adida, C., and Altieri, D.C. (1997). A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, 917-921.
4. Baird, G.S., Zacharias, D.A., and Tsien, R.Y. (2000). Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl. Acad. Sci. USA 97, 11984-11989.
5. Banks, D.P., Plescia, J., Altieri, D.C., Chen, J., Rosenberg, S.H., Zhang, H., and Ng, S.C. (2000). Survivin does not inhibit caspase-3 activity. Blood 96, 4002-4003.
6. Berberich-Siebelt, F., Klein-Hessling, S., Santner-Nannan, B., Hepping, N., Lindemann, D., Schimpl, A., Berberich, I., and Serfling, E. (2000). C/EBPβ enhances IL-4 but impairs IL-2, and IFN-g induction in T cells. Eur. J. Immunol. 30, 2576-2585.
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 772, 248-254.
8. Conn, C.W., Hennigan, R.F., Dai, W., Sanchez, Y., and Stambrook, P.J. (2000). Incomplete cytokinesis, and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. Cancer Res. 60, 6826-6831.
9. Conway, E.M., Pollefeyt, S., Cornelissen, J., DeBaere, I., Steiner-Mosonyi, M., Ong, K., Baens, M., Collen, D., and Schuh, A.C. (2000). Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions. Blood 95, 1435-1442.
10. Crook, N.E., Clem, R.J., and Miller, L.K. (1993). An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67, 2168-2174.
11. Deveraux, Q.L., and Reed, J.C. (1999). IAP family proteins - suppressors of apoptosis. Genes Dev. 13, 1253-1262.
12. DuBridge, R.B., Tang, P., Hsia, H.C., Leong, P.M., Miller, J.H., and Calos, M.P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
13. Endoh, A., Asanuma, K., Moriai, R., Yamada, M., Koyanagi, Y., Sato, T., Yagihasi, A., Nakamura, M., Kobayashi, D., and Watanabe, N. (2001). Expression of survivin mRNA in CD34-positive cells. Clin. Chim. Acta 306, 149-151.
14. Fortugno, P., Wall, N.R., Giodini, A., O'Connor, D.S., Plescia, J., Padgett, K.M., Tognin, S., Marchisio, P.C., and Altieri, D.C. (2002). Survivin exists in immunochemically distinct subcellular pools, and is involved in spindle microtubule function. J. Cell. Sci. 115, 575-585.
15. Grossman, D., McNiff, J.M., Li, F., and Altieri, D.C. (1999). Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 113, 1076-1081.
16. Grossman, D., Kim, P.J., Schechner, J.S., and Altieri, D.C. (2001). Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98, 635-640.
17. Gudz TI, Tserng KY, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. (1997). J. Biol. Chem. 272, 24154-24158.
18. Hofer, A., Nagel, F., Wonka, F., Krinke, H.E., Golfert, F., and Funk, R.H. (1999). A new perfusion cell chamber system for determination of heat shock effects by means of video-enhanced microscopy. Med. Biol. Eng. Comput. 37, 667-669.
19. Kaitna, S., Mendoza, M., Jantsch-Plunger, V, and Glotzer, M. (2000). INCENP, and an Aurora-like kinase form a complex essential for chromosome segregation, and efficient completion of cytokinesis. Curr. Biol. 10, 1172-1181.
20. Kalajzic, I., Stover, M.L., Liu, P., Kalajzic, Z., Rowe, D.W., and Lichtler, A.C. (2001). Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology 284, 37-45.
21. Kallio, M.J., Nieminen, M., and Eriksson, J.E. (2001). Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation, and mitotic exit. FASEB J. 15, 2721-2723.
22. Kobayashi, K., Hatano, M., Otaki, M., Ogasawara, T., and Tokuhisa, T. (1999). Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc. Natl. Acad. Sci. USA 96, 1457-1462.
23. Konno, R., Yamakawa, H., Utsunomiya, H., Ito, K., Sato, S., and Yajima, A. (2000). Expression of survivin, and Bcl-2 in the normal human endometrium. Mol. Hum. Reprod. 6, 529-534.
24. Laemmli, U.K. (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227, 680-686.
25. Li, F., Ackermann, E.J., Bennett, C.F., Rothermel, A.L., Plescia, J., Tognin, S., Villa, A., Marchisio, P.C., and Altieri, D.C. (1999). Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1, 461-466.
26. Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., and Altieri, D.C. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580-584.
27. Mackay, A.M., Ainsztein, A.M., Eckley, D.M., and Eamshaw, W.C. (1998). A dominant mutant of inner centromere protein (INCENP), a chromosomal protein, disrupts prometaphase congression and cytokinesis. J. Cell Biol. 140, 991-1002.
28. Mahotka, C., Wenzel, M., Springer, E., Gabbert, H.E., and Gerharz, C.D. (1999). Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 59, 6097-6102.
29. Mesri, M., Wall, R.W., Li, J., Kim, R.W., and Altieri, D.C. (2001). Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108, 981-990.
30. Muchmore, S.W., Chen, J., Jakob, C., Zakula, D., Matayoshi, E.D., Wu, W., Zhang, H., Li, F., Ng, S.C., and Altieri, D.C. (2000). Crystal structure, and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol. Cell. 6, 173-182.
31. O'Connor, D.S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P.C., and Altieri, D.C. (2000). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, 13103-13107.
32. Powers, J., Bossinger, O., Rose, D., Strome, S., and Saxton, W. (1998). A nematode kinesin required for cleavage furrow advancement. Curr. Biol. 8, 1133-1136.
33. Rodriguez, J.A., Span, S.W., Ferreira, C.G., Kruyt, F.A., and Giaccone, G. (2002). CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp. Cell Res. 275, 44-53.
34. Schmitz, M., Diestelkoetter, P., Weigle, B., Schmachtenberg, F., Stevanovic, S., Ockert, D., Rammensee, H.G., and Rieber, E.P. (2000). Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res. 60, 4845-4849.
35. Shi, Y. (2000). Survivin structure: crystal unclear. Comment in Nat. Struct. Biol. 8, 620-623.
36. Shin, S., Sung, B.J., Cho, Y.S., Kim, H.J., Ha, N.C., Hwang, J.I., Chung, C.W., Jung, Y.K., and Oh, B.H. (2001). An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3, and -7. Biochemistry 40, 1117-1123.
37. Skoufias, D.A., Mollinari, C., Lacroix, F.B., and Margolis, R.L. (2000). Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 25, 1575-1582.
38. Soneoka, Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Romano, G., Kingsman, S.M., and Kingsman, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
39. Tatsuka, M., Katayama, H., Ota, T., Tanaka, T., Odashima, S., Suzuki, F., and Terada, Y. (1998). Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. 58, 4811-4816.
40. Uren, A.G., Coulson, E.J., and Vaux, D.L. (1998). Conservation of baculovirus inhibitor of apoptosis repeat proteins BIRps in viruses, nematodes and yeast. Trends Biochem. Sci. 23, 59-162.
41. Uren, A.G., Wong, L., Pakusch, M., Fowler, K.J., Burrows, F.J., Vaux, D.L., and Choo, K.H. (2000). Survivin, and the inner centromere protein INCENP show similar cell-cycle localization, and gene knockout phenotype. Curr. Biol. 10, 1319-1328.
42. Verdecia, M.A., Huang, H., Dutil, E., Kaiser, A., Hunter, T., and Noel, J.P. (2000). Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7, 620-623.
43. Wheatley, S.P., Carvalho, A., Vagnarelli, P., and Earnshaw, W.C. (2001). INCENP is required for proper targeting of Survivin to the centromeres, and the anaphase spindle during mitosis. Curr. Biol. 11, 886-890.
44. Wheatley, S.P., Kandels-Lewis, S.E., Adams, R.R., Ainsztein, A.M., and Earnshaw, W.C. (2001b). INCENP binds directly to tubulin, and requires dynamic microtubules to target to the cleavage furrow. Exp. Cell Res. 262, 122-127.
45. Yarbrough, D., Wachter, R.M., Kallio, K., Matz, M.V., and Remington, S.J. (2001). Refined crystal structure of DsRed, a red fluorescent protein from coral, at 2.0-A resolution. Proc. Natl. Acad. Sci. USA 98, 462-467.
46. Zhao, J., Tenev, T., Martins, L.M., Downward, J., and Lemoine, N.R. (2000). The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 113, 4363-4371.